We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Clorox (CLX) Down 1.5% Since Last Earnings Report: Can It Rebound?
Read MoreHide Full Article
It has been about a month since the last earnings report for Clorox (CLX - Free Report) . Shares have lost about 1.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Clorox due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Clorox Q3 Earnings & Sales Beat on Solid Demand
Clorox reported third-quarter fiscal 2022 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Despite rising inflation and continued uncertainty, results gained from solid demand for its products and brand strength. Also, management is encouraged by the company’s portfolio, innovation pipeline, cost savings efforts and pricing actions.
Adjusted earnings of $1.31 per share decreased 19% year over year but surpassed the Zacks Consensus Estimate of 97 cents. The earnings decline can be attributed to lower gross margin which was partly offset by reduced advertising spending and higher sales. Adjusted earnings excluded 10 cents related to investments in the company's long-term digital capabilities and productivity enhancements.
The company posted net sales of $1,809 million, beating the Zacks Consensus Estimate of $1,808 million. The top line rose 2% both year over year and on an organic basis. Sales gained from higher shipments across all segments.
The gross margin contracted 760 basis points (bps) to 35.9% in the fiscal third quarter. Elevated manufacturing and logistics costs, and higher commodity costs was partly offset by pricing benefits and cost savings initiatives.
Segmental Discussion
Sales of the Health and Wellness segment declined 3% to $662 million, owing to soft sales across all three business units. The downside was led by a 3-point related to higher trade spending and a 3-point impact from unfavorable price mix which more than offset 3 points of pricing benefit.
The Household segment’s sales improved 6% to $539 million, driven by sales growth in two of the three business units stemming from 4 point of pricing gains and 2 point of higher volumes.
Sales at the Lifestyle segment rose 4% year over year to $306 million owing to growth across all three businesses. This was mainly due to a 6-point rise in volume which was somewhat offset by 2 point impact from unfavorable price mix.
In the International segment, sales of $302 million were up 1% year over year as an 4-point gain from favorable price mix and 2 point of rise in volumes was fully offset by a 5-point impact from unfavorable currency. Organic sales for the segment improved 6%.
Financials
Clorox ended third-quarter fiscal 2022 with cash and cash equivalents of $241 million, and long-term debt of $1,887 million. In the first nine months of fiscal 2022, the company generated $451 million of net cash from operations.
Fiscal 2022 Guidance
Management updated its fiscal 2022 view to take into account the adverse impacts from cost inflation. The gross margin is now expected to decline 800 bps in fiscal 2022 compared with a 750 bps decline mentioned earlier. The revised gross margin guidance stems from higher-than-anticipated commodity costs, and manufacturing and logistics expenses.
Consequently, adjusted earnings for fiscal 2022 are estimated to be $4.05-$4.30 per share, down from $4.25-$4.50 per share mentioned earlier. The revised guidance suggests a year-over-year decline of 44-41% compared with a decline of 41-38% stated earlier. The company notes that adjusted earnings per share will exclude long-term investments in digital capabilities and productivity enhancements to provide greater visibility to the underlying operating performance.
On a GAAP basis, earnings per share are anticipated to be $3.60-$3.85, down from $3.80-$4.05 stated earlier. The new guidance suggests a decline of 35-31% from the year-ago period compared with the 32-27% decline mentioned earlier.
It still envisions a sales decline of 1-4%, both on a reported and organic basis, for fiscal 2022. For the first half of fiscal 2022, sales is likely to decline 7%.
The company now projects selling and administrative expenses as a percentage of sales to be 14-15% for fiscal 2022, compared with prior view of 15%. This view includes 1% of this impact to come from the planned investments in digital capabilities and productivity enhancements.
Clorox stated that it expects to invest $90 million in long-term strategic digital capabilities and productivity enhancements in fiscal 2022. Of this, it expects $73 million (45 cents per share) to flow through to the profit and loss statement, most of which is expected to be recorded in selling and administrative expenses.
The company expects advertising and sales promotion expenses to be 10% of net sales. The higher spending mainly relates to an increase in brand investments to support its innovation pipeline and customer engagement efforts. The effective tax rate is anticipated at 22-23%.
Business Developments
The company continues to gain market share, marking the third straight quarter of double-digit growth for its disinfecting wipes. During the quarter, Clorox launched Kingsford flavor boosters for charcoal and pellet grills, Glad compostable drawstring bags in Canada, Glad to Be Green 50% ocean bound plastic recycled trash bags in Australia as well as Glad ForceFlex Plus with Clorox trash bags available in Eucalyptus and Peppermint fragrances.
Also, it inked a multiyear deal with ASM Global to become their official cleaning and disinfecting product partner. As part of the deal, ASM Global facilities will use Clorox disinfecting wipes, hand sanitizer and electrostatic sprayers. In another development, it announced a new 12-year virtual power purchase agreement in sync with its commitment to 100% renewable electricity for its U.S. and Canada operations.
How Have Estimates Been Moving Since Then?
It turns out, estimates review have trended downward during the past month.
The consensus estimate has shifted -28.18% due to these changes.
VGM Scores
Currently, Clorox has an average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Clorox has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry Player
Clorox belongs to the Zacks Soap and Cleaning Materials industry. Another stock from the same industry, Colgate-Palmolive (CL - Free Report) , has gained 5.8% over the past month. More than a month has passed since the company reported results for the quarter ended March 2022.
Colgate-Palmolive reported revenues of $4.4 billion in the last reported quarter, representing a year-over-year change of +1.3%. EPS of $0.74 for the same period compares with $0.80 a year ago.
Colgate-Palmolive is expected to post earnings of $0.73 per share for the current quarter, representing a year-over-year change of -8.8%. Over the last 30 days, the Zacks Consensus Estimate has changed -4.5%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #4 (Sell) for Colgate-Palmolive. Also, the stock has a VGM Score of B.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Clorox (CLX) Down 1.5% Since Last Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for Clorox (CLX - Free Report) . Shares have lost about 1.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Clorox due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Clorox Q3 Earnings & Sales Beat on Solid Demand
Clorox reported third-quarter fiscal 2022 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Despite rising inflation and continued uncertainty, results gained from solid demand for its products and brand strength. Also, management is encouraged by the company’s portfolio, innovation pipeline, cost savings efforts and pricing actions.
Adjusted earnings of $1.31 per share decreased 19% year over year but surpassed the Zacks Consensus Estimate of 97 cents. The earnings decline can be attributed to lower gross margin which was partly offset by reduced advertising spending and higher sales. Adjusted earnings excluded 10 cents related to investments in the company's long-term digital capabilities and productivity enhancements.
The company posted net sales of $1,809 million, beating the Zacks Consensus Estimate of $1,808 million. The top line rose 2% both year over year and on an organic basis. Sales gained from higher shipments across all segments.
The gross margin contracted 760 basis points (bps) to 35.9% in the fiscal third quarter. Elevated manufacturing and logistics costs, and higher commodity costs was partly offset by pricing benefits and cost savings initiatives.
Segmental Discussion
Sales of the Health and Wellness segment declined 3% to $662 million, owing to soft sales across all three business units. The downside was led by a 3-point related to higher trade spending and a 3-point impact from unfavorable price mix which more than offset 3 points of pricing benefit.
The Household segment’s sales improved 6% to $539 million, driven by sales growth in two of the three business units stemming from 4 point of pricing gains and 2 point of higher volumes.
Sales at the Lifestyle segment rose 4% year over year to $306 million owing to growth across all three businesses. This was mainly due to a 6-point rise in volume which was somewhat offset by 2 point impact from unfavorable price mix.
In the International segment, sales of $302 million were up 1% year over year as an 4-point gain from favorable price mix and 2 point of rise in volumes was fully offset by a 5-point impact from unfavorable currency. Organic sales for the segment improved 6%.
Financials
Clorox ended third-quarter fiscal 2022 with cash and cash equivalents of $241 million, and long-term debt of $1,887 million. In the first nine months of fiscal 2022, the company generated $451 million of net cash from operations.
Fiscal 2022 Guidance
Management updated its fiscal 2022 view to take into account the adverse impacts from cost inflation. The gross margin is now expected to decline 800 bps in fiscal 2022 compared with a 750 bps decline mentioned earlier. The revised gross margin guidance stems from higher-than-anticipated commodity costs, and manufacturing and logistics expenses.
Consequently, adjusted earnings for fiscal 2022 are estimated to be $4.05-$4.30 per share, down from $4.25-$4.50 per share mentioned earlier. The revised guidance suggests a year-over-year decline of 44-41% compared with a decline of 41-38% stated earlier. The company notes that adjusted earnings per share will exclude long-term investments in digital capabilities and productivity enhancements to provide greater visibility to the underlying operating performance.
On a GAAP basis, earnings per share are anticipated to be $3.60-$3.85, down from $3.80-$4.05 stated earlier. The new guidance suggests a decline of 35-31% from the year-ago period compared with the 32-27% decline mentioned earlier.
It still envisions a sales decline of 1-4%, both on a reported and organic basis, for fiscal 2022. For the first half of fiscal 2022, sales is likely to decline 7%.
The company now projects selling and administrative expenses as a percentage of sales to be 14-15% for fiscal 2022, compared with prior view of 15%. This view includes 1% of this impact to come from the planned investments in digital capabilities and productivity enhancements.
Clorox stated that it expects to invest $90 million in long-term strategic digital capabilities and productivity enhancements in fiscal 2022. Of this, it expects $73 million (45 cents per share) to flow through to the profit and loss statement, most of which is expected to be recorded in selling and administrative expenses.
The company expects advertising and sales promotion expenses to be 10% of net sales. The higher spending mainly relates to an increase in brand investments to support its innovation pipeline and customer engagement efforts. The effective tax rate is anticipated at 22-23%.
Business Developments
The company continues to gain market share, marking the third straight quarter of double-digit growth for its disinfecting wipes. During the quarter, Clorox launched Kingsford flavor boosters for charcoal and pellet grills, Glad compostable drawstring bags in Canada, Glad to Be Green 50% ocean bound plastic recycled trash bags in Australia as well as Glad ForceFlex Plus with Clorox trash bags available in Eucalyptus and Peppermint fragrances.
Also, it inked a multiyear deal with ASM Global to become their official cleaning and disinfecting product partner. As part of the deal, ASM Global facilities will use Clorox disinfecting wipes, hand sanitizer and electrostatic sprayers. In another development, it announced a new 12-year virtual power purchase agreement in sync with its commitment to 100% renewable electricity for its U.S. and Canada operations.
How Have Estimates Been Moving Since Then?
It turns out, estimates review have trended downward during the past month.
The consensus estimate has shifted -28.18% due to these changes.
VGM Scores
Currently, Clorox has an average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Clorox has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry Player
Clorox belongs to the Zacks Soap and Cleaning Materials industry. Another stock from the same industry, Colgate-Palmolive (CL - Free Report) , has gained 5.8% over the past month. More than a month has passed since the company reported results for the quarter ended March 2022.
Colgate-Palmolive reported revenues of $4.4 billion in the last reported quarter, representing a year-over-year change of +1.3%. EPS of $0.74 for the same period compares with $0.80 a year ago.
Colgate-Palmolive is expected to post earnings of $0.73 per share for the current quarter, representing a year-over-year change of -8.8%. Over the last 30 days, the Zacks Consensus Estimate has changed -4.5%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #4 (Sell) for Colgate-Palmolive. Also, the stock has a VGM Score of B.